Literature DB >> 27474880

Incidence and risk factors for anastomotic stenosis of continuous hepaticojejunostomy after pancreaticoduodenectomy.

Tomonari Asano1,2, Seiji Natsume3, Yoshiki Senda1, Tsuyoshi Sano4, Keitaro Matsuo5, Yasuhiro Kodera2, Kazuo Hara6, Seiji Ito1, Kenji Yamao6, Yasuhiro Shimizu1.   

Abstract

BACKGROUND: There have been no reports showing the incidence of anastomotic stenosis of continuous hepaticojejunostomy (HJ) and identifying its risk factors for patients who underwent pancreaticoduodenectomy (PD).
METHOD: We retrospectively investigated 200 patients whose HJ was established by unified method, single layered continuous suture. HJ stenosis was diagnosed with endoscopic or radiologic examinations. Uni and multivariable unconditional logistic modeling were performed to explore the predictive factors and to estimate odds ratios (ORs) and their 95% confidence intervals (CIs).
RESULTS: Sixteen patients (8.0%) were diagnosed as HJ stenosis. Multivariable analysis showed that body mass index (BMI) (OR: 1.24; 95% CI: 1.03-1.51), absence of preoperative biliary stenting (OR: 11.10; 95% CI: 1.22-101.12), operative time (OR: 1.74 per one hour increase; 95% CI: 1.01-2.98), age (OR: 1.58 per 10 years increase; 95% CI: 0.88-2.85), and absence of nodal metastasis (OR: 3.43; 95% CI: 0.90-13.12) correlated with HJ stenosis. Among these, BMI and preoperative biliary stenting were associated with stenosis with a lower P-value than the others (P = 0.026 and 0.033, respectively).
CONCLUSIONS: The incidence of HJ stenosis was 8.0%. Close attention would be needed especially for patients at high risk of HJ stenosis, such as high BMI or absence of preoperative biliary stenting.
© 2016 Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Entities:  

Keywords:  Anastomotic stenosis; Continuous hepaticojejunostomy; Pancreaticoduodenectomy

Mesh:

Year:  2016        PMID: 27474880     DOI: 10.1002/jhbp.385

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  5 in total

1.  Double-balloon endoscopy-assisted treatment of hepaticojejunostomy anastomotic strictures and predictive factors for treatment success.

Authors:  Tatsuya Sato; Hirofumi Kogure; Yousuke Nakai; Kazunaga Ishigaki; Ryunosuke Hakuta; Kei Saito; Tomotaka Saito; Naminatsu Takahara; Tsuyoshi Hamada; Suguru Mizuno; Atsuo Yamada; Minoru Tada; Hiroyuki Isayama; Kazuhiko Koike
Journal:  Surg Endosc       Date:  2019-06-19       Impact factor: 4.584

2.  Long-term outcomes of EUS-guided transluminal stent deployment for benign biliary disease: Multicenter clinical experience (with videos).

Authors:  Takeshi Ogura; Mamoru Takenaka; Hideyuki Shiomi; Daisuke Goto; Takashi Tamura; Takeshi Hisa; Hironari Kato; Nobu Nishioka; Kosuke Minaga; Atsuhiro Masuda; Takumi Onoyama; Masatoshi Kudo; Kazuhide Higuchi; Masayuki Kitano
Journal:  Endosc Ultrasound       Date:  2019 Nov-Dec       Impact factor: 5.628

3.  Mechanism of scar formation following Roux-en-Y choledochojejunostomy in a novel rat model of obstructive jaundice.

Authors:  Shao-Cheng Lyu; Jing Wang; Lin Zhou; Ji-Qiao Zhu; Fei Pan; Tao Jiang; Ren Lang; Qiang He
Journal:  Ann Transl Med       Date:  2021-03

4.  Economics and safety of continuous and interrupted suture hepaticojejunostomy: An audit of 556 surgeries.

Authors:  Rajan Saxena; Nalini Kanta Ghosh; Saurabh Galodha
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2021-11-30

5.  Continuous or interrupted suture technique for hepaticojejunostomy? A national survey.

Authors:  Maximilian Brunner; Jessica Stockheim; Christian Krautz; Dimitrios Raptis; Stephan Kersting; Georg F Weber; Robert Grützmann
Journal:  BMC Surg       Date:  2018-10-11       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.